HSE banner

HM Nuclear Installations Inspectorate

AMERSHAM PLC., GROVE CENTRE SITE, AMERSHAM

Quarterly report for 1 JULY - 30 SEPTEMBER 2003

CONTENTS


FOREWORD

This report is issued as part of the Health and Safety Executive's commitment to make information about inspection and regulatory activities relating to the above site available to the public. It is for distribution to members of the Amersham plc, Grove Centre Local Liaison Committee (LLC) and covers activities associated with the regulation of safety at the site. These reports are distributed quarterly. Site Inspectors of HM Nuclear Installations Inspectorate attend LLC meetings and will be happy to respond to questions raised there by members of the LLC. Any other person wishing to inquire about matters covered by this report should contact the HSE, Nuclear Directorate Information Centre on 0151 - 951 - 4103.


[back to top]

INSPECTIONS

Visits by the NII to the Grove Centre site were made on 2 - 4 and 23 - 24 September 2003.


[back to top]

ROUTINE MATTERS

The main thrust of NII activity during the period of this report has been regulatory compliance and the site emergency exercise.

Routine compliance inspection of plant was carried out to the inspection plan and the site inspector on each of his visits has inspected parts of the site. Particular attention has been paid to the compliance by the licensee with Licence Conditions 19 (Construction or Installation of New Plant) and 20 (Modification to Design of Plant Under Construction). The fundamental requirements needed for compliance with both Licence Conditions was noted.

The Grove Centre Site Annual Emergency Exercise was held on 24 September 2003 and was witnessed by the NII. Overall the exercise was judged to provide an adequate demonstration of the site emergency arrangements. Evidence of good practice was seen during the exercise and a number of areas for improvement were noted.

An NII specialist radiological inspector together with the site inspector met with Amersham to discuss a proposed project for manufacturing a therapeutic product labelled with iodine-131 for the treatment of Non-Hodgkin's lymphoma. The meeting served to identify the principal radiological health and safety issues arising from the project. The NII indicated to Amersham that it was likely to take regulatory control of the project under Licence Condition 19 (Construction or Installation of New Plant).

The new Superintending Inspector covering Amersham sites regulation made a familiarisation visit to the site. Amersham gave a presentation covering site operations and visits were made to manufacturing areas and decommissioning facilities.


[back to top]

NON-ROUTINE MATTERS

No statutory reportable radiological incidents have been notified to the NII this quarter.


[back to top]

REGULATORY ACTIVITY

No legal instruments were issued during the quarter.


Published on the HSE web site 20 February 2004